Kestine Flash

Ebastine, the active ingredient in Kestine Flash, is a second‑generation H1 antihistamine presented as an oral tablet for oral use. It alleviates symptoms of allergic rhinitis and chronic idiopathic urticaria in adults and adolescents and is approved for symptomatic relief of nasal congestion, sneezing, itching and watery eyes.

GNH USA supplies Kestine Flash as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance, regulatory compliance and reliable global logistics. Our network ensures timely delivery to diverse healthcare settings.

Ebastine is a second‑generation antihistamine that reduces allergic inflammation in the nasal passages and skin.

Allergic rhinitis: reduces nasal congestion, sneezing, itching and watery discharge. Chronic idiopathic urticaria: decreases frequency and severity of hives and itching. Allergic skin reactions: provides relief from itching and erythema caused by histamine release. Seasonal allergic conjunctivitis: alleviates eye itching and redness associated with pollen exposure.

Ebastine is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Dry mouth: transient sensation of oral dryness. - Fatigue: feeling of tiredness without exertion. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or throat requiring urgent care. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: rare systemic allergic response that can be life‑threatening.

Before prescribing Ebastine, clinicians should consider several safety aspects. - Assess liver function: monitor patients with hepatic impairment before initiating therapy. - Avoid in known hypersensitivity: discontinue if an allergic reaction occurs. - Pregnancy caution: limited data, use only if benefit outweighs risk. - Elderly caution: may experience increased sedation. - Drug interaction review: evaluate concomitant medications that affect CYP3A4. - Store at ambient temperature: keep in original container, protect from moisture.

Ebastine may interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - Ketoconazole: may increase plasma concentrations of ebastine. - Ritonavir: can markedly raise ebastine levels. - Erythromycin: may elevate ebastine exposure.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive sedative effect may occur. - Alcohol: can enhance drowsiness. - Other antihistamines: may lead to excessive antihistaminic effect.